#Merck
3 articles with this tag

Healthcare
Today in AI: mRNA Cancer Vaccine Clears Phase 3
Moderna and Merck said their personalized mRNA cancer vaccine hit phase 3 endpoints in melanoma, the first success after 1,000 failures.
about 1 month ago

Artificial Intelligence
Moderna-Merck Melanoma Vaccine Shows Promising Results
Moderna and Merck have announced positive Phase 3 trial results for their personalized mRNA cancer vaccine, demonstrating a significant reduction in melanoma recurrence. This development marks a major step forward in cancer treatment.
about 2 months ago

Investors News
AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders
First-of-its-Kind AI/Pharma and Computational Biology Innovation Lab Appoints Former Senior Pharma Executive as CEO and Senior Computational Scientist as CTO
almost 5 years ago